A novel prostate cancer immunotherapy using prostate-specific antigen peptides and Candida skin test reagent as an adjuvant.

Al-Ola AbdallahHannah ColemanMohamed KamelRodney DavisTeri LandrumHorace SpencerSam MackintoshFade A MahmoudNatasa MilojkovicChester WickerKonstantinos ArnaoutakisMayumi Nakagawa

Published in: SAGE open medicine (2018)

In summary, a design and a formulation of a novel prostate cancer immunotherapy are described. The immunogenicity of prostate-specific antigen peptides in some prostate cancer patients supports further development of this immunotherapy.

Keyphrases

prostate cancer
radical prostatectomy
early stage
drug delivery
amino acid
candida albicans
biofilm formation
escherichia coli
staphylococcus aureus